Treatment of adult patients with acute lymphocytic leukemia in relapse

References

• Clavell L. A., Gelber R. D., Cohen H. J., Hitchcock-Bryan S., Cassady J. R., Tarbell N. J., Blattner S. R., Tantravahi R., Leavitt P., Sallan S. E. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N. Engl. J. Med. 1986; 315: 657–663
   PubMed Web of Science ®Google Scholar
• Riehm H., Gadner H. Results and significance of six randomized trials in four consecutive ALL-BFM studies. Haematology and Blood Transfusion 33, T. Buchner, G. Schellong. Springer-Verlag, Berlin 1990; 439–450
   Google Scholar
• Rivera G. K., Raimondi S. C., Hancock M. L., Behm F. G., Pui C.-H., Abromowitch M., Mirro J., Jr., Ochs J. S., Look A. T., Williams D. L., Murphy S. B., Dahl G. V., Kalwinsky D. K., Evans W. E., Kun L. E., Simone J. V., Crist W. M. Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet 1991; 337: 61–66
   PubMed Web of Science ®Google Scholar
• Henze G., Fengler R. BFM group treatment results in relapsed childhood acute lymphoblastic leukemia. Haematology and Blood Transfusion 33, T. Buchner, G. Schellong. Springer-Verlag, Berlin 1990; 619–626
   Google Scholar
• Pui C.-H., Bowman W. P., Ochs J., Dodge R. K., Rivera C. K. Cyclic combination chemotherapy for acute lymphoblastic leukemia recurring after elective cessation of therapy. Med. Pediatr. Oncol. 1988; 16: 21–26
   PubMedGoogle Scholar
• Bleyer W. A., Sather H., Hammon G. D. Prognosis and treatment after relapse of acute lymphoblastic leukemia and non-Hodgkin's lymphoma. 1985. A report from the Children's Cancer Study Group. Cancer 1986; 58: 590–594
   PubMedGoogle Scholar
• Buchanan G. R., Rivera G. K., Boyett J. M., Chauvenet A. R., Crist W. M., Vietti T. J. Reinduction therapy in 297 children with acute lymphoblastic leukemia in first bone marrow relapse: A Pediatric Oncology Group study. Blood 1988; 72: 1286–1292
   PubMed Web of Science ®Google Scholar
• Hoelzer D. F. Therapy of the newly diagnosed adult with acute lymphoblastic leukemia. Hem. Oncol. Clin North Am. 1993; 7: 139–160
   PubMed Web of Science ®Google Scholar
• Gimema Cooperative Group. GIMEMA ALL 0183: A multicentric study on adult acute lymphoblastic leukaemia in Italy. Br. J. Haematol. 1989; 71: 377–386
   PubMed Web of Science ®Google Scholar
• Linker C:. A., Levitt L. J., O'Donnell M., Ries C. A., Link M. P., Forman S. J., Farbstein M. J. Improved results of treatment of adult lymphoblastic leukemia. Blood 1987; 69: 1242–1248
   PubMed Web of Science ®Google Scholar
• Linker C. A., Levitt L. J., O'Donnell M., Forman S. J., Ries C. A. Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: A follow-up report. Blood 1991; 78: 2814–2822
   PubMed Web of Science ®Google Scholar
• Jacobs P., Wood L. Treatment of acute lymphoblastic leukaemia (ALL). Eur. J. Haematol. 1992; 49: 53–58
   PubMed Web of Science ®Google Scholar
• Bassan R., Battista R., D'Emilio A., Viero P., Dragone P., Dini E., Barbui T. Long-term results of the HEAVD protocol for adult acute lymphoblastic leukaemia. Eur. J. Cancer 1991; 27: 441–447
   PubMed Web of Science ®Google Scholar
• Cuttner J., Mick R., Budman D. R., Mayer R. J., Lee E. J., Henderson E. s, Weiss R. B., Paciucci P. A., Sobol R., Davey F. Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALG study. Leukemia 1991; 5: 425–431
   PubMed Web of Science ®Google Scholar
• Cassileth P. A., Andersen J. W., Bennet J. M., Hoagland H. C., Mazza J. J., O'Connell M. C., Paietta A., Wiernik P. Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience. Leukemia. 1992; 6: 178–181, Suppl 2
   PubMed Web of Science ®Google Scholar
• Wiernik P., Dutcher J. P., Paietta E., Gucalp R., Markus S., Weinberg V., Azar C., Garl S., Benson L. Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthracycline containing regimen. Leukemia Lymphoma. 1993; 6: 1236–1241
   Google Scholar
• Suki S., Kantarjian H., Gandhi V., Estey E., O'Brien S., Beran M., Rios M. B., Plunkett W., Keating M. Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia. Cancer. 1993; 72: 2155–2160
   PubMed Web of Science ®Google Scholar
• Schiller G., Lee M., Territo M., Gajewski J., Nimer S. Phase II study of etoposide. ifosfamide, and mitoxantrone for the treatment of resistant adult acute lymphoblastic leukemia. Am. J. Hematol. 1993; 43: 195–199
   PubMed Web of Science ®Google Scholar
• Liso V., Specchia G., Capalbo S., Pavone V., Iacobazzi A., Iaculli M. L., Dione R., Pansini N. Mitoxantrone and continuous infusion of cytosine arabinoside in refractory and relapsed acute lymphoblastic leukemia. Acta Haematol. 1992; 87: 54–57
   PubMed Web of Science ®Google Scholar
• Freund M., Diedrich H., Ganser A., Gramatzki M., Heil G., Heyll A., Henke M., Hiddemann W., Haas R., Kuse R., Koch P., Link H., Maschmeyer G., Planker M., Queiber W., Schadeck-Gressel C., Schmitz N., Von Verschuer U., Wilhelm S., Thiel E., Hoelzer D. Treatment of relapsed or refractory adult acute lymphocytic leukemia. Cancer. 1992; 69: 709–716
   PubMed Web of Science ®Google Scholar
• Hoelzer D., Thiel E., Loffler H., Buchner T., Ganser A., Heil G., Koch P., Freund M., Diedrich H., Ruhl H., Maschmeyer G., Lipp T., Nowrousian M. R., Gerecke D., Pralle H., Muller U., Cunscken Ch., Fulle H., Ho A. D., Kuchler R., Busch F. W., Schneider W., Gorg Ch., Emmerich B., Braumann D., Vaupel H. A., Von Paleske A., Bartels H., Neiss A., Messerer D. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood. 1988; 71: 123–131
   PubMed Web of Science ®Google Scholar
• Welborn J. L. Impact of reinduction regimens for relapsed and refractory acute lymphoblastic leukemia in adults. Am. J. Hematol. 1994; 45: 341–344
   PubMed Web of Science ®Google Scholar